Variant report
Variant | nsv1018037 |
---|---|
Chromosome Location | chr7:12048555-12064626 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2966622 | chr7:12048555-12048556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147724884 | chr7:12048573-12048574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73294729 | chr7:12048586-12048587 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs554552539 | chr7:12048594-12048595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142488990 | chr7:12048631-12048632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146566899 | chr7:12048658-12048659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184415235 | chr7:12048661-12048662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139127688 | chr7:12048709-12048710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs36094560 | chr7:12048714-12048715 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs149362340 | chr7:12048745-12048746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566791779 | chr7:12048784-12048785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538433833 | chr7:12048790-12048791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143643098 | chr7:12048802-12048803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs374951170 | chr7:12048811-12048812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537952266 | chr7:12048823-12048824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554095958 | chr7:12048827-12048828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533925449 | chr7:12048924-12048925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574114583 | chr7:12048926-12048927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553569616 | chr7:12048956-12048957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576653343 | chr7:12048968-12048969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs545617208 | chr7:12048973-12048974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116123426 | chr7:12049030-12049031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2215987 | chr7:12049086-12049087 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs189236657 | chr7:12049091-12049092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2215986 | chr7:12049120-12049121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373612947 | chr7:12049124-12049125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182027297 | chr7:12049153-12049154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530487279 | chr7:12049164-12049165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114139094 | chr7:12049169-12049170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540786612 | chr7:12049170-12049171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562159733 | chr7:12049172-12049173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs78062683 | chr7:12049174-12049175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562035635 | chr7:12049269-12049270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527670091 | chr7:12049272-12049273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184300507 | chr7:12049288-12049289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111852703 | chr7:12049302-12049303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs78326496 | chr7:12049310-12049311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188778618 | chr7:12049323-12049324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148068971 | chr7:12049329-12049330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569033846 | chr7:12049342-12049343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559276441 | chr7:12049350-12049351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141800065 | chr7:12049356-12049357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529662814 | chr7:12049363-12049364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547905120 | chr7:12049399-12049400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528551111 | chr7:12055616-12055617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571422098 | chr7:12055619-12055620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73676182 | chr7:12055754-12055755 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs201863263 | chr7:12055759-12055760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537044692 | chr7:12055779-12055780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182245444 | chr7:12055796-12055797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Autism | 22495309 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:12048400-12048600 | Enhancers | Fetal Kidney | kidney |
2 | chr7:12048400-12049000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr7:12048400-12049200 | Enhancers | Small Intestine | intestine |
4 | chr7:12048800-12049400 | Enhancers | Fetal Brain Female | brain |
5 | chr7:12055600-12057800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr7:12057800-12059200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr7:12059200-12059400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr7:12059400-12059800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr7:12059600-12060000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr7:12059800-12062400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr7:12061000-12061600 | Enhancers | Fetal Lung | lung |